Brean Murray initiates coverage on CytRx Corp. (NASDAQ: CYTR) with a Buy rating and a $3 price target.
...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE